While stocks have enjoyed a strong start to 2024, CNBC Pro found there are still plenty of opportunities for investors looking for companies that offer cheap growth potential. The S&P 500 index jumped 10.2% in the first quarter, while the Dow Jones Industrial Average and Nasdaq Composite gained 5.6% and 9.1%, respectively. The first two days of the second trimester start in the best way. The three major averages are all down more than 1%. So far, only the energy sector is positive for the month. The technology sector, which has driven the market’s gains since October 2023, fell about 1.2% in April. With this in mind, CNBC Pro has selected stocks that can offer investors “growth at a reasonable price,” or GARP. This is a popular investment methodology that focuses on stocks with strong growth prospects and attractive valuations, combining offensive and defensive characteristics in one portfolio. The screening showed that GARP opportunities exist in a broad range of sectors of the S&P 500. The names met all of the following criteria: Earnings per share growth above 10% Sales growth above 10% Trading at a discount to their S & P 500 Sector on a 12-Month Basis Several consumer discretionary names have made it to the GARP list. Cruise line Royal Caribbean and casino company Las Vegas Sands could both grow their earnings by more than 40% this fiscal year. Royal Caribbean currently trades at a forward P/E ratio of 13.2, while Las Vegas Sands has a forward P/E of 18.4. RCL LVS,.SPX YTD mountain Royal Caribbean and Las Vegas Sands vs. S&P 500 in 2024 Restaurant chain Yum Brands also appeared. The stock lags the S&P 500 in 2024, rising 6.8% versus the broader market’s 8.8% rise. But according to analyst estimates, Taco Bell’s parent company will see earnings per share grow 12% in 2024. Healthcare names Cigna Group and Cardinal Health are other GARP opportunities for investors. Cigna trades at a forward P/E ratio of 12.2, with earnings estimated to rise 13.3%. The stock has already rallied nearly 21% since the beginning of the year. Cardinal Health’s earnings could rise 26%. The stock trades at a slightly higher forward P/E ratio than Cigna, at 14.3. Shares rise 9.9% in 2024.